EMA Publishes New Union Procedure on the Management of Pharmacovigilance Inspection Findings
July 2014Focus on Regulation - Hogan Lovells Blog
On 20 June 2014, the European Medicines Agency (hereafter “EMA”) published a new European Union procedure on the management of pharmacovigilance inspection findings which may impact the robustness of the benefit-risk profile of the concerned medicinal products (“new EU Procedure”). The new EU Procedure came into effect on 1 June 2014.
To read the full article please click here.